DaVita Shares Rise on 4Q Earnings Beat

Dow Jones21:09

By Elias Schisgall

Shares of DaVita were higher after the company's fourth-quarter earnings came in above Wall Street expectations.

Shares were up 12% at $124.06 in pre-market trading Tuesday. The stock closed Monday at $111.19, down 37% over the past year.

The kidney care provider on Monday posted a profit of $234.2 million, or $3.29 a share, compared with $259.3 million, or $3.09 a share, a year earlier.

Stripping out certain one-time items, the company logged adjusted earnings of $3.40 a share. Analysts polled by FactSet were expecting $3.24 a share.

Revenue rose to $3.62 billion, up from $3.29 billion a year earlier. Analysts were expecting $3.51 billion.

For the full year, DaVita said it expects adjusted earnings of between $13.60 and $15.00 a share. Analysts polled by FactSet were expecting $12.82 prior to the earnings release.

The company is also projecting adjusted operating income between $2.09 billion and $2.24 billion and free cash flow between $1 billion and $1.25 billion.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

February 03, 2026 08:09 ET (13:09 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2608792578?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 21:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608792578","market":"sh","top_or_hot":-1,"title":"DaVita Shares Rise on 4Q Earnings Beat","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of DaVita were higher after the company's fourth-quarter earnings came in above Wall Street expectations. \n</p>\n<p>\n  Shares were up 12% at $124.06 in pre-market trading Tuesday. The stock closed Monday at $111.19, down 37% over the past year. \n</p>\n<p>\n  The kidney care provider on Monday posted a profit of $234.2 million, or $3.29 a share, compared with $259.3 million, or $3.09 a share, a year earlier. \n</p>\n<p>\n  Stripping out certain one-time items, the company logged adjusted earnings of $3.40 a share. Analysts polled by FactSet were expecting $3.24 a share. \n</p>\n<p>\n  Revenue rose to $3.62 billion, up from $3.29 billion a year earlier. Analysts were expecting $3.51 billion. \n</p>\n<p>\n  For the full year, DaVita said it expects adjusted earnings of between $13.60 and $15.00 a share. Analysts polled by FactSet were expecting $12.82 prior to the earnings release. \n</p>\n<p>\n  The company is also projecting adjusted operating income between $2.09 billion and $2.24 billion and free cash flow between $1 billion and $1.25 billion. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 03, 2026 08:09 ET (13:09 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita Shares Rise on 4Q Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita Shares Rise on 4Q Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-03 21:09</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of DaVita were higher after the company's fourth-quarter earnings came in above Wall Street expectations. \n</p>\n<p>\n  Shares were up 12% at $124.06 in pre-market trading Tuesday. The stock closed Monday at $111.19, down 37% over the past year. \n</p>\n<p>\n  The kidney care provider on Monday posted a profit of $234.2 million, or $3.29 a share, compared with $259.3 million, or $3.09 a share, a year earlier. \n</p>\n<p>\n  Stripping out certain one-time items, the company logged adjusted earnings of $3.40 a share. Analysts polled by FactSet were expecting $3.24 a share. \n</p>\n<p>\n  Revenue rose to $3.62 billion, up from $3.29 billion a year earlier. Analysts were expecting $3.51 billion. \n</p>\n<p>\n  For the full year, DaVita said it expects adjusted earnings of between $13.60 and $15.00 a share. Analysts polled by FactSet were expecting $12.82 prior to the earnings release. \n</p>\n<p>\n  The company is also projecting adjusted operating income between $2.09 billion and $2.24 billion and free cash flow between $1 billion and $1.25 billion. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 03, 2026 08:09 ET (13:09 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2608792578","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2608792578","pubTimestamp":1770124140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of DaVita were higher after the company's fourth-quarter earnings came in above Wall Street expectations.Shares were up 12% at $124.06 in pre-market trading Tuesday. The stock closed Monday at $111.19, down 37% over the past year.The kidney care provider on Monday posted a profit of $234.2 million, or $3.29 a share, compared with $259.3 million, or $3.09 a share, a year earlier.Stripping out certain one-time items, the company logged adjusted earnings of $3.40 a share. Analysts polled by FactSet were expecting $3.24 a share.Revenue rose to $3.62 billion, up from $3.29 billion a year earlier. Analysts were expecting $3.51 billion.For the full year, DaVita said it expects adjusted earnings of between $13.60 and $15.00 a share. Analysts polled by FactSet were expecting $12.82 prior to the earnings release.The company is also projecting adjusted operating income between $2.09 billion and $2.24 billion and free cash flow between $1 billion and $1.25 billion.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健","BK4588":"碎股","BK4196":"保健护理服务","BK4585":"ETF&股票定投概念","BK4559":"巴菲特持仓"},"translate_title":"DaVita股价因第四季度盈利超出预期而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":0.9},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Shares of DaVita were higher after the company's fourth-quarter earnings came in above Wall Street expectations. \n\n\n  Shares were up 12% at $124.06 in pre-market trading Tuesday. The stock closed Monday at $111.19, down 37% over the past year. \n\n\n  The kidney care provider on Monday posted a profit of $234.2 million, or $3.29 a share, compared with $259.3 million, or $3.09 a share, a year earlier. \n\n\n  Stripping out certain one-time items, the company logged adjusted earnings of $3.40 a share. Analysts polled by FactSet were expecting $3.24 a share. \n\n\n  Revenue rose to $3.62 billion, up from $3.29 billion a year earlier. Analysts were expecting $3.51 billion. \n\n\n  For the full year, DaVita said it expects adjusted earnings of between $13.60 and $15.00 a share. Analysts polled by FactSet were expecting $12.82 prior to the earnings release. \n\n\n  The company is also projecting adjusted operating income between $2.09 billion and $2.24 billion and free cash flow between $1 billion and $1.25 billion. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 03, 2026 08:09 ET (13:09 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2608792578","isCrawlerRequest":true}